MI Systemic lupus erythematosus (SLE) research has focused primarily on adaptive immunity. There is a growing body of literature implicating a role for dendritic cells (DCs) in many of the disease ...

Systemic lupus erythematosus (SLE ... coupled with a better understanding of SLE pathogenesis, have renewed interest in this disease area. Product candidates are in development for different ...

However, symptoms often overlap with those of systemic lupus erythematosus (SLE). These include: muscle and joint pain sometimes with swelling flu-like symptoms of fatigue and fever serositis ...

July 10, 2024 — Scientists have discovered a molecular defect that promotes the pathologic immune response in systemic lupus erythematosus (known as lupus) and show that reversing this defect ...

Interferon-alpha activity may be used routinely in clinical settings as a biomarker for cutaneous lupus erythematosus and ...

More than 50% of patients with systemic lupus erythematosus (SLE) develop lupus nephritis (LN) during the disease, which may ...

A 23-year-old white woman with systemic lupus erythematosus (SLE ... cAPS was not thought to have a critical role in the pathogenesis of her coma. Medications were not thought to have induced ...

Background SLE is a systemic autoimmune disease with a large number of common risk gene variants, but several rare gene ...

Conduit Pharmaceuticals partners with Charles River to evaluate the efficacy of its lead programme in a pre-clinical lupus model, utilizing ...

The odds of developing systemic lupus erythematosus or systemic sclerosis appear to significantly increase with the use of ...

Biogen has bagged $250 million to advance a key pipeline prospect. | Biogen has bagged $250 million to advance a key pipeline ...

MI Systemic lupus erythematosus (SLE) research has focused primarily on adaptive immunity. There is a growing body of literature implicating a role for dendritic cells (DCs) in many of the disease ...